The prices of popular weight loss drugs Ozempic and Wegovy are to fall dramatically from next year, Danish drugmaker Novo Nordisk said Tuesday.
The list price of Wegovy will be cut in half on January 1, 2027, plummeting from around $1,350 to $675 a month. The cost of Ozempic will fall to $675 - around a third less than its current $1,027 monthly cost. Novo Nordisk’s diabetes pill Rybelsus, which sells for nearly $1,000 right now, will cost $675.